Your browser doesn't support javascript.
loading
Blinatumomab as a bridge to further therapy in cases of overwhelming toxicity in pediatric B-cell precursor acute lymphoblastic leukemia: Report from the Israeli Study Group of Childhood Leukemia.
Elitzur, Sarah; Arad-Cohen, Nira; Barzilai-Birenboim, Shlomit; Ben-Harush, Miriam; Bielorai, Bella; Elhasid, Ronit; Feuerstein, Tamar; Gilad, Gil; Gural, Alexander; Kharit, Mira; Litichever, Naomi; Nirel, Ronit; Weinreb, Sigal; Wolach, Ofir; Toren, Amos; Izraeli, Shai; Jacoby, Elad.
Afiliação
  • Elitzur S; The Rina Zaizov Division of Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva, Israel.
  • Arad-Cohen N; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Barzilai-Birenboim S; Pediatric Hematology-Oncology Department, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Ben-Harush M; The Rina Zaizov Division of Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva, Israel.
  • Bielorai B; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Elhasid R; Department of Pediatric Hematology-Oncology, Soroka Medical Center, Ben Gurion University, Beer Sheva, Israel.
  • Feuerstein T; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Gilad G; Division of Pediatric Hematology, Oncology and BMT, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel.
  • Gural A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Kharit M; Pediatric Hemato-Oncology, Sourasky Medical Center, Tel Aviv, Israel.
  • Litichever N; The Rina Zaizov Division of Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva, Israel.
  • Nirel R; The Rina Zaizov Division of Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva, Israel.
  • Weinreb S; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Wolach O; Department of Hematology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
  • Toren A; Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Izraeli S; The Rina Zaizov Division of Pediatric Hematology-Oncology, Schneider Children's Medical Center, Petah Tikva, Israel.
  • Jacoby E; Department of Statistics, Hebrew University, Jerusalem, Israel.
Pediatr Blood Cancer ; 66(10): e27898, 2019 10.
Article em En | MEDLINE | ID: mdl-31264788
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Anticorpos Biespecíficos / Antineoplásicos Imunológicos Tipo de estudo: Observational_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Anticorpos Biespecíficos / Antineoplásicos Imunológicos Tipo de estudo: Observational_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Israel